Skip to main content
. Author manuscript; available in PMC: 2008 Jun 1.
Published in final edited form as: Magn Reson Med. 2004 Dec;52(6):1234–1238. doi: 10.1002/mrm.20291

FIG. 2.

FIG. 2

The techniques applied to a subject with acute myelogenous leukemia: (a) coronal image from a baseline study obtained just prior to initiation of myelosuppressive therapy, (b) a second examination obtained 20 days later after the patient had achieved a remission. The bone marrow was intact at baseline with a water fraction of 0.99 ± 0.06 and a T2 of water equal to 61.7 ± 1.8 msec, which is consistent with the presence of leukemia. Twenty days after the start of chemotherapy, the water signal in the bone marrow on the T2- and diffusion-weighted images is virtually absent. The patient had achieved a complete remission at this time, with only 2% myeloblasts on the differential blood count.